- Home
- MATX vs GRFS Comparison
MATX vs GRFS Comparison
Compare MATX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MATX | GRFS |
|---|---|---|
| Founded | 1882 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.2B |
| IPO Year | 1994 | 2008 |
Fundamental Metrics
Financial Performance| Metric | MATX | GRFS |
|---|---|---|
| Price | $214.45 | $7.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $163.33 | $10.15 |
| AVG Volume (30 Days) | 304.5K | ★ 574.1K |
| Earning Date | 05-04-2026 | 07-28-2022 |
| Dividend Yield | 0.83% | ★ 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.10 | N/A |
| Revenue | ★ $3,344,500,000.00 | N/A |
| Revenue This Year | $4.65 | $4.49 |
| Revenue Next Year | $4.31 | $6.42 |
| P/E Ratio | $33.51 | ★ $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $86.97 | $6.96 |
| 52 Week High | $230.74 | $10.84 |
Technical Indicators
Market Signals| Indicator | MATX | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 56.08 |
| Support Level | $190.90 | $7.76 |
| Resistance Level | $229.37 | $8.36 |
| Average True Range (ATR) | 7.01 | 0.19 |
| MACD | -0.35 | 0.00 |
| Stochastic Oscillator | 55.39 | 50.00 |
Price Performance
Historical ComparisonAbout MATX Matson Inc.
Matson Inc is engaged in providing ocean transportation and logistics services. The company has two reportable business segments: Ocean Transportation and Logistics. The Ocean Transportation segment provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific. The Logistics segment offers long-haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from the Ocean Transportation segment.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.